Cytembena

CAS No. 21739-91-3

Cytembena( —— )

Catalog No. M34219 CAS No. 21739-91-3

Cytembena is a cytostatic and a carcinogenic compound that may increase the incidence of fibroadenomas.Cytembena broadly inhibits DNA biosynthesis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 200 In Stock
10MG 295 In Stock
25MG 557 In Stock
50MG 725 In Stock
100MG 1014 In Stock
200MG Get Quote In Stock
500MG 2027 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cytembena
  • Note
    Research use only, not for human use.
  • Brief Description
    Cytembena is a cytostatic and a carcinogenic compound that may increase the incidence of fibroadenomas.Cytembena broadly inhibits DNA biosynthesis.
  • Description
    Cytembena is a cytostatic and a carcinogenic compound that may increase the incidence of fibroadenomas.Cytembena broadly inhibits DNA biosynthesis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    DNA/RNA Synthesis
  • Recptor
    DNA/RNA Synthesis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    21739-91-3
  • Formula Weight
    307.07
  • Molecular Formula
    C11H8BrNaO4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COC1=CC=C(C(/C(Br)=C\C([O-])=O)=O)C=C1.[Na+]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Osalmid

    Osalmid is a choleretic drug.

  • Nedaplatin

    Nedaplatin is a derivative of cisplatin and DNA damage agent for tumor colony forming units with IC50 of 94 μM.

  • Talviraline

    Talviraline (Bay 10-8979) is an RNA-induced DNA polymerase inhibitor.Talviraline is a potent inhibitor of HIV-1-induced cell killing and HIV-1 replication in a variety of human cell lines, as well as in fresh human peripheral blood lymphocytes and macrophages.